Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$548.35 - $738.84 $3,290 - $4,433
6 Added 0.31%
1,912 $1.13 Million
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $1.13 Million - $1.33 Million
1,906 New
1,906 $1.33 Million
Q4 2020

Feb 12, 2021

SELL
$478.3 - $607.98 $192,276 - $244,407
-402 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$544.75 - $658.21 $218,989 - $264,600
402 New
402 $225,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Ativo Capital Management LLC Portfolio

Follow Ativo Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ativo Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ativo Capital Management LLC with notifications on news.